{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:33:10Z","timestamp":1761975190572},"reference-count":16,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1016\/j.clindermatol.2010.11.008","type":"journal-article","created":{"date-parts":[[2011,4,18]],"date-time":"2011-04-18T09:53:13Z","timestamp":1303120393000},"page":"295-299","source":"Crossref","is-referenced-by-count":19,"title":["Current dilemmas and controversies in allergic contact dermatitis to ophthalmic medications"],"prefix":"10.1016","volume":"29","author":[{"given":"Elena S.","family":"Novitskaya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon J.","family":"Dean","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer P.","family":"Craig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anton B.","family":"Alexandroff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2010.11.008_bb0005","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/01.all.0000183112.86181.9e","article-title":"Allergic reaction to topical eyedrops","volume":"5","author":"Baudouin","year":"2005","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.clindermatol.2010.11.008_bb0010","doi-asserted-by":"crossref","first-page":"509","DOI":"10.2340\/00015555-0162","article-title":"Allergic contact dermatitis due to beta-blockers in eye drops: a retrospective analysis of multicentre surveillance data 1993-2004","volume":"86","author":"Jappe","year":"2006","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2010.11.008_bb0015","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/ACI.0b013e3283306990","article-title":"Allergy to ophthalmic preservatives","volume":"9","author":"Hong","year":"2009","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.clindermatol.2010.11.008_bb0020","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.2174\/138161206778194024","article-title":"Hypersensitivity reactions to ophthalmic products","volume":"12","author":"Ventura","year":"2006","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.clindermatol.2010.11.008_bb0025","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.0105-1873.2004.00334.x","article-title":"Allergic and non-allergic periorbital dermatitis: patch test results of the Information Network of the Departments of Dermatology during a 5-year period","volume":"51","author":"Herbst","year":"2004","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.clindermatol.2010.11.008_bb0030","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1080\/00015550410024102","article-title":"Doubtful value of patch testing for suspected contact allergy to ophthalmic products","volume":"85","author":"Corazza","year":"2005","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2010.11.008_bb0035","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1111\/j.1365-2133.2008.08790.x","article-title":"Periorbital dermatitis\u2014a recalcitrant disease: causes and differential diagnoses","volume":"159","author":"Feser","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2010.11.008_bb0040","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1080\/15569520902995834","article-title":"Ocular preservatives: associated risks and newer options","volume":"28","author":"Kaur","year":"2009","journal-title":"Cutan Ocul Toxicol"},{"key":"10.1016\/j.clindermatol.2010.11.008_bb0045","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/01.ico.0000243948.61354.5e","article-title":"Conjunctival provocation test for the diagnosis of ocular hypersensitivity to chlorobutanol","volume":"26","author":"Garcia-Medina","year":"2007","journal-title":"Cornea"},{"key":"10.1016\/j.clindermatol.2010.11.008_bb0050","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0536.2007.01126.x","article-title":"Allergic contact dermatitis from ophthalmics: 2007","volume":"57","author":"Chaudhari","year":"2007","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.clindermatol.2010.11.008_bb0055","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1053\/ajcd.2001.25129","article-title":"Contact dermatitis to topical drugs for glaucoma","volume":"12","author":"Holdiness","year":"2001","journal-title":"Am J Contact Dermat"},{"key":"10.1016\/j.clindermatol.2010.11.008_bb0060","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/00061198-199710000-00006","article-title":"Clinical experience with apraclonidine 0.5%","volume":"6","author":"Gross","year":"1997","journal-title":"J Glaucoma"},{"key":"10.1016\/j.clindermatol.2010.11.008_bb0065","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1185\/03007990802333167","article-title":"Comparison of allergy rates in glaucoma patients receiving brimonidine 0.2% monotherapy versus fixed-combination brimonidine 0.2%-timolol 0.5% therapy","volume":"24","author":"Motolko","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.clindermatol.2010.11.008_bb0070","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1442-9071.2008.01720.x","article-title":"Meta-analysis of randomized controlled trials comparing timolol with brimonidine in the treatment of glaucoma","volume":"36","author":"Loon","year":"2008","journal-title":"Clin Exper Ophthalmol"},{"key":"10.1016\/j.clindermatol.2010.11.008_bb0075","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/00061198-200006000-00006","article-title":"Incidence of brimonidine allergy in patients previously allergic to apraclonidine","volume":"9","author":"Williams","year":"2000","journal-title":"J Glaucoma"},{"key":"10.1016\/j.clindermatol.2010.11.008_bb0080","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1600-0536.1991.tb01879.x","article-title":"Contact dermatitis caused by allergy to ophthalmic drugs and contact lens solutions","volume":"25","author":"Herbst","year":"1991","journal-title":"Contact Dermatitis"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X10002166?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X10002166?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,3]],"date-time":"2018-12-03T07:27:20Z","timestamp":1543822040000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X10002166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S0738081X10002166"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2010.11.008","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}